Granules India Limited
NSE: GRANULES.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Krishna Prasad Chigurupati
- Employees
- 4,057
- Headquarters
- Hyderabad, India
- IPO year
- 2005
- Market cap
- ₹186.6B
- Website
- https://www.granulesindia.com
Loading GRANULES…
Loading profile data…Frequently asked questions about GRANULES
What does Granules India Limited (GRANULES.NS) do?
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensive...
Where does GRANULES.NS trade?
Granules India Limited (GRANULES.NS) trades on the National Stock Exchange of India.
What sector is GRANULES.NS in?
Granules India Limited (GRANULES.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Granules India Limited?
Krishna Prasad Chigurupati is the chief executive officer of Granules India Limited (GRANULES.NS).
Where is Granules India Limited headquartered?
Granules India Limited is headquartered in India.
Does GRANULES.NS pay a dividend?
Yes — Granules India Limited (GRANULES.NS) paid a trailing twelve-month dividend of INR 1.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GRANULES.NS go public?
Granules India Limited (GRANULES.NS) completed its initial public offering in 2005.